Monthly Archives: November 2024

//November

Guidance on managing IT issues

Community Pharmacy England regularly receives queries or requests for advice about system-specific IT issues, and we have recently updated our factsheet to support pharmacy owners and their teams. Although we can assist with service or payment-related processes, addressing technical issues falls outside of our remit and you should contact your IT system supplier or IT [...]

The post Guidance on managing IT issues appeared first on Community Pharmacy England.

By |November 13th, 2024|Lexpos News|Comments Off on Guidance on managing IT issues

Parliamentarians urge Government action to support community pharmacies in letter to Health Secretary

20 parliamentarians have signed a letter to the Secretary of State for Health and Social Care, Wes Streeting MP, calling for urgent government action to safeguard the future of community pharmacies. Supported by Community Pharmacy England, the cross-party letter describes the financial challenges facing the sector and calls on the Department of Health and Social [...]

The post Parliamentarians urge Government action to support community pharmacies in letter to Health Secretary appeared first on Community Pharmacy England.

By |November 13th, 2024|Lexpos News|Comments Off on Parliamentarians urge Government action to support community pharmacies in letter to Health Secretary

DEADLINE EXTENDED: Help inform review of sector costs

The deadline to register interest in participating in an important fiscal review of the community pharmacy sector has been extended to Monday 18th November. With pharmacies across the country struggling to cope under intolerable financial pressures, NHS England’s independent economic review offers an opportunity to demonstrate how much it actually costs to run a pharmacy [...]

The post DEADLINE EXTENDED: Help inform review of sector costs appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on DEADLINE EXTENDED: Help inform review of sector costs

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) Drug alert number: EL (24)A/54 Date issued: 12 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole 40mg Powder for solution for infusion. Company name: Viatris [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)

Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium fusidate (Fucidin®) 250mg tablets and fusidic acid (Fucidin®) 250mg/5ml oral suspension MSN/2024/107 Tier 2 medium impact Date of issue: 7th October 2024 Sodium fusidate (Fucidin®) 250mg tablets will be discontinued from mid-January 2025. Fusidic acid (Fucidin®) 250mg/5ml oral suspension will [...]

The post Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Sodium fusidate (Fucidin® ) 250mg tablets and fusidic acid (Fucidin® ) 250mg/5ml oral suspension